复旦大学附属妇产科医院病理科医生。医学博士，从事病理诊断工作6年。目前从事妇产科专科病理诊断工作。

学习经历：

1997.09-2002.06 东南大学医学院临床医学专业本科

2002.09-2005.06 中山大学中山医学院病理生理学硕士

2008.09-2011.06 复旦大学医学院妇产科学博士

2014.10-2015.04 美国匹兹堡大学医学中心Magee妇产科医院病理科访问学者

工作经历：

2005.07-2006.09 广东佛山中医院病理科医生

2006.10-2008.08 上海浦东公利医院病理科医生

2011.07-2012.01 复旦大学附属妇产科医院妇产科医生

2012.1至今 复旦大学附属妇产科医院病理科主治医生

承担课题：

1.  TRPC3膜定位及其下游信号通路影响卵巢癌顺铂耐药的机制. 国家自然基金青年项目(2015-2017，编号81402151)

2.  子宫内膜间质细胞参与子宫内膜癌变过程的机制研究. 教育部高等学校博士学科点专项科研基金新教师类(2013-2015，编号20120071120084)

发表论文：

1.  X Tao, CC Griffith, X Zhou, Z Wang, Y Yan, Z Li, C Zhao. History of High Risk HPV Testing and Pap Test Results in a Large Cohort of Patients with Invasive Cervical Carcinoma: Experience from the Largest Women Hospital in China. Cancer Cytopathol (In press)

2.  Li, S., Y. Xie, W. Zhang, J. Gao, M. Wang, G. Zheng, X. Yin, H. Xia and X. Tao (2015). Interferon alpha-inducible protein 27 promotes epithelial-mesenchymal transition and induces ovarian tumorigenicity and stemness. J Surg Res 193(1): 255-264. (correspondence author)

3.  Zhang, C., W. Hu, N. Jia, Q. Li, K. Hua, X. Tao, L. Wang and W. Feng (2015). Uterine Carcinosarcoma and High-Risk Endometrial Carcinomas: A Clinicopathological Comparison. Int J Gynecol Cancer. [Epub ahead of print]

4.  Tao X, Xie Y, Wang L, Gu W, Yu X, Zhou X. The expression of Cox-2, NF-κB and VEGF in ectopic endometrial tissues within fallopian tubes suggests different etiologies. International Journal of Gynecological Pathology. 2014;33(4):411-417.

5.  Tao X, Zhao N, Jin H, Zhang Z, Liu Y, Wu J, Bast RC, Jr., Yu Y, Feng Y. FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3. Endocrine-related cancer 2013;20(3): 415-429.

6.  Jiang W*, Tao X*, Fang F, Zhang S, Xu C. Benign and malignant ovarian steroid cell tumors, not otherwise specified: case studies, comparison, and review of the literature. Journal of ovarian research 2013;6(1): 53. (* Co-first author)

7.  Xie Y, Tao X, Cheng Z, Guan Q, Yang W, Zhu Y. Discrepancy of uterine leiomyoma and myometrium to hypoxia-induced endoplasmic reticulum stress after uterine occlusion therapy accounts for therapeutic effect. Arch Gynecol Obstet 2013, 289(5): 1039-1045.

8.  Liu Y, Tao X, Fan L, Jia L, Gu C, Feng Y. Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer. Molecular medicine reports 2012;6(5): 1050-1056.

9.  Liu Y, Tao X, Jia L, Cheng KW, Lu Y, Yu Y, Feng Y. Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells. Molecular medicine reports 2012;6(5): 1006-1012.

10.  Cheng ZP, Tao X, Gong J, Dai H, Hu LP, Yang WH. Early-stage morphological observations of myoma and myometrium after laparoscopic uterine artery occlusion treatment. European journal of obstetrics, gynecology, and reproductive biology 2009;145(1): 113-116.

11.  Zhang XY, Ding JX, Tao X, Hua KQ. FSH stimulates expression of the embryonic gene HMGA2 by downregulating let-7 in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas. Experimental and therapeutic medicine 2013;5(1): 350-354.

12.  Xuyin Z, Jingxin D, Xiang T, Luoqi J, Keqin H. Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma. Oncology letters 2012;4(5): 1008-1012.

13.  Zhang Y, Ding JX, Tao X, Lu ZY, Wang JJ, Feng WW, Hua KQ. Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study. Journal of chemotherapy 2013;25(2): 96-103.

发表会议摘要：

1.  X Tao, Z Li, X Zhou, Z Wang, Y Yan, C Zhao. History of High Risk HPV Testing and Pap Test Results in a Large Cohort of Patients with Cervical Carcinoma: Experience from the Largest Women Hospital in China. United States and Canadian Academy of Pathology (USCAP) 2015

2.  X Tao, H Jin, Z Zhang, RC Bast Jr, Y Feng, Y Yu. Downregulation of TRPC3 enhances sensitivity to cisplatin and inhibits motility in epithelial ovarian cancer. American Association of Cancer Research (AACR) 2014

3.  X Tao, H Jin, RC Bast Jr, Y Liu, Y Yu, Y Feng. Follicle-stimulating hormone (FSH) enhances the proliferation of epithelial ovarian cancer cells by activating transient receptor potential channel C3 (TRPC3). American Association of Cancer Research (AACR) 2011